Liz Hockley
Key details
- Title: Writer and sub editor
- Email:lhockley@lifesciencesipreview.com
.
Total results: 225
Articles by Liz Hockley
Americas
US State Department has said it is engaging with Chinese officials to resolve situation | Federal employee failed to disclose he worked for US government, according to a report. 25 July 2025
Americas
Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | BMS’s Indian patent covering the monoclonal antibody expires in May 2026. 21 July 2025
Europe
Office declined application, citing earlier authorisations for inhalers designed for people containing the same ingredient | Boehringer argued that ciclesonide was a ‘new active substance’ not previously authorised for a veterinary product in the EU. 8 July 2025
Americas
Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion’ of Prolia and XGEVA in 2025 driven by biosimilar competition | Sandoz launched interchangeable versions of bone drugs last month following settlement in 2024. 2 July 2025
Americas
Judge says sale of genetic data is ‘scary proposition’ but that blanket ban could result in missed opportunities | Former CEO Anne Wojcicki will repurchase business that she co-founded and ran for years. 1 July 2025
Americas
Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly delaying market entry of generic Pomalyst | Lawsuit follows dismissal of antitrust suit against pharma giant over same drug. 26 June 2025
Americas
Appeals board overturns previous decision and revokes patent on treatment worth $2bn in 2024 | Teva and Generics UK successful in arguing lack of inventive step. 24 June 2025
Biotech
Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to be anticipated by prior art. 12 June 2025
Americas
New York court finds Ethicon breached agreement with ChemImage over advanced imaging technologies | Parties dispute damages for IP ‘impairment’. 3 June 2025
Americas
Shilpa Medicare failed to prove invalidity of patent covering Lenvima | Eisai says ruling keeps India-based generic maker’s product off the market until 2036. 29 May 2025
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.